The efficacy of nucleoside analog (NA) prodrugs in anticancer and antiviral treatments is often impaired by the slow intracellular activation of these drugs. NAs are administered as the uncharged nucleoside to achieve effective intracellular concentrations. Once inside the cell, NAs require conversion to their triphosphorylated form to become pharmacologically active. The sequential three-step phosphorylation is carried out by human cellular kinases, with the first step, catalyzed by nucleoside kinases, most often being rate limiting. For example, both AZT and d4T require conversion into their monophosphate form by human thymidine kinase, which for d4T is the rate-limiting step in its activation. To address the problem of inefficient NA activation we propose to structurally and kinetically characterize human thymidine kinases. Vertebrates have two different thymidine kinases, a cytosolic form (hTK1) and a mitochondrial form (hTK2). Activity of hTK1 is high in proliferating cells and peaks during the S-phase of the cell cycle, while hTK2 is constitutively expressed at low levels. To understand the molecular determinants of substrate specificity, enzymatic mechanism, and regulatory mechanisms of human thymidine kinases we propose to: (1) Solve the crystal structures of hTK1 in complex with substrates and NA prodrugs. (2) Delineate the regulatory mechanisms controlling hTK1 activity. (3) Characterize the determinants of substrate specificity and investigate the catalytic mechanism of hTK2. (4) Delineate the structural reasons that confer high d4T-phosphorylating activity of the homologous T. maritima thymidine kinase. (5) Based on the results from the previous aims, design and produce mutants of the human enzymes that possess higher activity and improved specificity for clinically relevant prodrugs. Together, the proposed work will dramatically increase our understanding of these important enzymes. In addition, the results will improve our abilities to develop NAs that are selectively activated by TK1 and not by TK2, a major goal since activation by TK2 often results in toxic side effects. A long-term goal of this project is to engineer enzymes that possess improved prodrug activation efficiencies to be employed in antiviral and anticancer therapies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI046943-07
Application #
7369869
Study Section
AIDS Discovery and Development of Therapeutics Study Section (ADDT)
Program Officer
Zhang, Hao
Project Start
1999-12-01
Project End
2010-02-28
Budget Start
2008-03-01
Budget End
2010-02-28
Support Year
7
Fiscal Year
2008
Total Cost
$250,043
Indirect Cost
Name
University of Illinois at Chicago
Department
Biochemistry
Type
Schools of Medicine
DUNS #
098987217
City
Chicago
State
IL
Country
United States
Zip Code
60612
McSorley, Theresa; Ort, Stephan; Hazra, Saugata et al. (2008) Mimicking phosphorylation of Ser-74 on human deoxycytidine kinase selectively increases catalytic activity for dC and dC analogues. FEBS Lett 582:720-4
Segura-Pena, Dario; Lichter, Joseph; Trani, Manuela et al. (2007) Quaternary structure change as a mechanism for the regulation of thymidine kinase 1-like enzymes. Structure 15:1555-66
Sekulic, Nikolina; Dietrich, Kristen; Paarmann, Ingo et al. (2007) Elucidation of the active conformation of the APS-kinase domain of human PAPS synthetase 1. J Mol Biol 367:488-500
Segura-Pena, Dario; Lutz, Stefan; Monnerjahn, Christian et al. (2007) Binding of ATP to TK1-like enzymes is associated with a conformational change in the quaternary structure. J Mol Biol 369:129-41
Sekulic, Nikolina; Konrad, Manfred; Lavie, Arnon (2007) Structural mechanism for substrate inhibition of the adenosine 5'-phosphosulfate kinase domain of human 3'-phosphoadenosine 5'-phosphosulfate synthetase 1 and its ramifications for enzyme regulation. J Biol Chem 282:22112-21
Segura-Pena, Dario; Sekulic, Nikolina; Ort, Stephan et al. (2004) Substrate-induced conformational changes in human UMP/CMP kinase. J Biol Chem 279:33882-9
Ostermann, Nils; Segura-Pena, Dario; Meier, Chris et al. (2003) Structures of human thymidylate kinase in complex with prodrugs: implications for the structure-based design of novel compounds. Biochemistry 42:2568-77
Sekulic, Nikolina; Shuvalova, Ludmila; Spangenberg, Oliver et al. (2002) Structural characterization of the closed conformation of mouse guanylate kinase. J Biol Chem 277:30236-43